2.71 (-%)
As of Nov 29, 2024
Source:
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue and skeleton. Through our in-depth understanding of a key biological pathway, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 857-330-4340 |
Industry | manufacturing |
CEO | Douglas A. Treco |
Website | www.inozyme.com |